chemotherapy

Case study: 20 non-melanomas and now this mysterious lesionIn this case, the clinical diagnosis can be difficult as the features of the lesion overlap in this 90-year-old patient. What is the diagnosis?
Three improvements data promises to deliverPersonalized, prescriptive medicine creates higher-value care for patients
Ocular surface tumors require careful exam, consideration of best options
Ocular surface tumors require careful exam, consideration of best optionsAlthough surgery is still the gold standard for ocular surface tumors, consider the pros and cons of topical chemotherapy as appropriate.
Selective techniques revolutionize treatment for retinoblastomaAdvancements in retinoblastoma have occurred in the areas of treatment, genetic testing, and diagnostic imaging.
Immuno-oncology bladder drug wins approvalSoon after approving the same drug for metastatic Merkel cell carcinoma, FDA approved immuno-oncology avelumab (Bavencio) for locally advanced or metastatic urothelial carcinoma.
Skin cancer quick reference
Skin cancer quick referenceThe May Table of the Month goes over tips for properly diagnosing skin cancer types.
Predictive analytics reduces chemotherapy-associated hospitalizationsPatient risk can improve value-based cancer care. Find out how.
Aggressive price growth pushes healthcare spending upRise in use of outpatient care and professional services contributed to quicker growth in spending for the privately insured over previous years.
Biomarkers: Top challenges and opportunities in managed careBiomarkers, if used appropriately, could ensure patients receive the appropriate treatment sooner, and that they have better outcomes at reduced costs. But despite the potential and expanding capabilities, barriers to full-fledged use remain.
FDA approves trifluridine/tipiracil for colorectal cancerLonsurf is a new, orally administered cytotoxic drug for the treatment of patients with metastatic colorectal cancer.